|
Indian Pediatr 2016;53: 741-742 |
|
Health Related Quality
of Life in Patients with Transfusion-dependent Thalassemia
|
Sachin Soni, Rajat Thawani, Tushar Idhate, Manas Kalra
and *Amita Mahajan
Department of Pediatric Hematology/Oncology,
Indraprastha Apollo Hospitals, New Delhi, India.
Email: [email protected]
Published online: June 01, 2016.
PII:S097475591600004
|
Patients with transfusion-dependent thalassemia are expected to have an
unfavorable quality of life due to multiple factors. We studied the
quality of life in 72 patients (age 5-39 y) with transfusion-dependent
thalassemia in the era of improved care, and assessed different
parameters affecting it.
Keywords: Beta-thalassemia, Blood transfusion, Outcome.
|
Transfusion-dependent thalassemia has a negative
impact on the quality of life (QoL) because of the disease, and its
treatment [1]. Recent advances in management such as access to safer
blood and oral chelation are expected to improve QoL in these patients
[2]. We aimed to study the QoL of transfusion-dependent thalassemia
patients and evaluate the effect of multiple variables on different
domains of QoL.
This study was conducted at a day-care center of a
hospital, and an outreach clinic for patients with limited resources.
Patients over the age of five were enrolled in the study. QoL of
thalassemia patients was measured using the PedsQL Version 4.0 [3]. A
structured questionnaire was developed for collecting information after
pilot testing. Children who were unable to read or write were
interviewed. Data were collected regarding the socioeconomic status
(SES), mean pre-transfusion hemoglobin, frequency of blood transfusions,
mode of chelation, adequacy of chelation and presence of complications.
The PedsQL version 4.0 was used to calculate the QoL in 4 domains:
physical, emotional, social, and school functioning. For older patients,
we modified school functioning as work functioning to make the results
comparable.
Seventy-two patients (20 females) between the ages 5
to 39 years were included with mean (SD) age of 14.6 (7.6) years. Nearly
half (48.6%) of the patients maintained their pre-transfusion hemoglobin
above 9 g/dL. The majority (72.2%) received oral deferasirox for
chelation. Mean serum ferritin over the preceding one year was
calculated, and 19.4% had a level of less than 1000 µg/mL, 48.7% had a
level between 1000-2500 µg/mL, and 31.9% had a ferritin level above 2500
µg/mL. We found that 20.8% of patients had liver dysfunction due to
viral hepatitis or iron overload, 23.6% had growth failure, 4.1% had
osteoporosis, and 16.6% had multiple complications (endocrinopathy along
with above listed complications).
The mean (SD) QoL scores for physical functioning was
83.1 (16.6), emotional functioning was 78.8 (18.5), social functioning
was 88.6 (20.3), and school functioning was 82.8 (17.8). We found a
negative correlation between age and social functioning (P=0.02).
A significant difference was observed in levels of school functioning
between patients without any complication when compared to the ones with
liver dysfunction (P= 0.048). We found no statistical difference
in QoL amongst patients receiving treatments in the two setups.
Previous studies using PedsQL have shown mean QoL
scores for physical functioning, emotional functioning, social
functioning and school functioning between 68.4-69.1, 68.1-76.9,
74.3-83.7, and 60.1-69.4, respectively. Our results show a higher QoL
for patients of transfusion-dependent thalassemia [4-6]. The higher QoL
in our patients can be attributed to optimal chelation, easy access to
safe blood products, flexible timing of transfusion, regular counseling
and patient support.
We found that older patients had poorer social
functioning; this could be because of increased awareness about the
impact of the disease on finding gainful employment, marriage, and
parenthood. Liver dysfunction was seen to have more detrimental effect
on the functional status of patients than any other complication
attributable to thalassemia.
Contributors: SS: acquisition of data, and
drafting the work; RT: analysis and interpretation of data, and drafting
the work; TI: acquisition of data, and drafting the work; MK, AM:
Concept and design of study, and revising the draft.
Funding: None; Competing interest:
None stated.
References
1. Wahyuni MS, Ali M, Rosdiana N, Lubis B. Quality of
life assessment of children with thalassemia. Paediatr Indones.
2011;51:207-12.
2. Ali SS, Tarawah AM, Al-Hawsawi ZM, Zolaly MA,
Turkustani W. Comprehensive patient care improves quality of life in
transfusion dependent patients with
a-thalassemia. Saudi Med J. 2015;36:575-9.
3. Varni JW. Scaling and scoring of the Pediatric
Quality of Life Inventory PedsQL. 2014. Available from:
http://www.pedsql.org/PedsQL-Scoring.pdf
4. Ismail A. Cambell MJ, Ibrahim HM, Jones GL. Health
Related Quality of Life in malaysian children with thalassemia. Health
Qual Life Outcomes. 2006;4:39.
5. Thavorncharoensap M, Torcharus K, Nuchprayoon I,
Riewpaiboon A, Indaratna K, Ubol B-O. Factors affecting health-related
quality of life in Thai children with thalassemia. BMC Blood Disord.
2010;10:1
6. Caocci G, Efficace F, Ciotti F, Roncarolo MG,
Vacca A, Piras E, et al. Health related quality of life in Middle
Easter children with beta-thalassemia. BMC Blood Disord. 2012;12:6.
|
|
|
|